Literature DB >> 13919843

[Research on the production of angiotensin II (hypertensin II)].

M TAUBERT, H H WAGNER.   

Abstract

Entities:  

Keywords:  HYPERTENSION/blood

Mesh:

Substances:

Year:  1962        PMID: 13919843     DOI: 10.1007/bf01483452

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  11 in total

1.  A new method of large-scale preparation of hypertensin, with a note on its assay.

Authors:  W S PEART
Journal:  Biochem J       Date:  1955-02       Impact factor: 3.857

2.  [Studies of extraction and determination of vasopressin in blood].

Authors:  M TAUBERT; K PFEFFER
Journal:  Arztl Forsch       Date:  1957-06-10

3.  Synthesis and pharmacology of the octapeptide angiotonin.

Authors:  F M BUMPUS; H SCHWARZ; I H PAGE
Journal:  Science       Date:  1957-05-03       Impact factor: 47.728

4.  The isolation of a hypertension.

Authors:  W S PEART
Journal:  Biochem J       Date:  1956-03       Impact factor: 3.857

5.  Pharmacology of renin and hypertension.

Authors:  E BRAUN-MENENDEZ
Journal:  Pharmacol Rev       Date:  1956-03       Impact factor: 25.468

6.  The substance causing renal hypertension.

Authors:  E Braun-Menendez; J C Fasciolo; L F Leloir; J M Muñoz
Journal:  J Physiol       Date:  1940-07-24       Impact factor: 5.182

7.  Suggested Revision of Nomenclature--Angiotensin.

Authors:  E Braun-Menendez; I H Page
Journal:  Science       Date:  1958-01-31       Impact factor: 47.728

8.  The preparation and function of the hypertensin-converting enzyme.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

9.  The amino acid sequence of hypertensin. II.

Authors:  L T SKEGGS; K E LENTZ; J R KAHN; N P SHUMWAY; K R WOODS
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307

10.  ON THE NATURE OF THE PRESSOR ACTION OF RENIN.

Authors:  I H Page
Journal:  J Exp Med       Date:  1939-10-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.